Treatment

FPI-2053 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
This study is testing a new medicine for people with advanced cancers that haven't responded to other treatments. It aims to see how safe the medicine is, how it moves through the body, and what dose works best.
For: Advanced Solid Tumor · Metastatic Colorectal Carcinoma · Head and Neck Squamous Cell Carcinoma
United States · Canada